Vilon is the Lys-Glu dipeptide studied in immune-signaling, cellular regulation, and gerontology-oriented laboratory models. The original overview of this page asks three questions: the Lys-Glu sequence and short-peptide classification, immune and cellular-aging model questions, and confirming identity when the target molecule is very small.
Editorial review: 17 November 2026. Prepared by Velnacor Research Desk for research-use communication only. Published findings below are attributed to the cited papers. They are not claims about a Velnacor lot and are not instructions for use in people or animals.
The Lys-Glu sequence and short-peptide classification
Khavinson and colleagues, in a systematic review of peptide regulation of gene expression, mapped the name Vilon to the dipeptide KE (Lys-Glu) and placed it among other short peptides with published name-to-sequence assignments, including KED (Vesugen), EDR (Pinealon), and AEDG (Epitalon) (Khavinson et al., 2021, Molecules). That mapping is the identity used on this page. KE is not KED, EDR, or AEDG, and a class label such as “bioregulator” is not a specification. A class overview is at What Are Bioregulator Peptides?.
Immune and cellular-aging model questions
The same systematic review discusses short peptides in the authors’ language of gene-expression regulation and of earlier reports that span several physiological systems (Khavinson et al., 2021, Molecules). That is a class-level synthesis. Citation flag. A KE-specific primary research paper, separate from that systematic review, was not independently verified for this draft. Immune-signaling or cellular-aging findings should not be transferred to Vilon from KED, EDR, or AEDG papers, and review language should not be restated as a completed clinical claim or as a use instruction.
Confirming identity when the target molecule is very small
A dipeptide needs methods suited to low mass: compositional or sequence identity, purity, content, and lot matching. A two-letter code is not a complete file until the report agrees. What Is a Peptide COA?, How to Read a Peptide COA, HPLC vs Mass Spectrometry for Peptide Lot Review, and lot traceability apply independently to this row.
Vilon was not found as a standalone published item in Velnacor’s current research-material catalog listing used for this draft (Epithalon and Thymalin are separate catalog rows). Use the product directory and the COA Library, then confirm whether a current SKU exists and which lot documents apply in the inquiry. For packing at supply scale, see wholesale peptides.
Because the molecule is only two residues, identity mistakes are easy: a typographical swap with KED, a class-only label, or a method chosen for a longer peptide. Orthogonal records—compositional or sequence identity, a purity trace suited to a dipeptide, and a lot number that matches the vial—are the useful checks. Findings published for Vesugen or Pinealon should stay on those pages. This identity note does not add an unverified immune-trial claim for KE.
Selected published literature
- Khavinson VK, Popovich IG, Linkova NS, Mironova ES, Ilina AR. Peptide regulation of gene expression: a systematic review. Molecules. 2021;26(22):7053. doi:10.3390/molecules26227053. PubMed 34834147. Open access: PMC8619776. Systematic review; cited for the KE/Vilon name mapping, not as a use instruction or as a substitute for a KE-specific primary paper.
Sourcing notes for qualified buyers
Velnacor’s stated supply terms for qualified research and business buyers include: every batch is third-party tested; orders usually ship within 24 hours, subject to stock, documentation review, and destination; trial orders can start from one box of ten vials; parcels lost or damaged in transit are eligible for free reshipment or a refund; and neutral packaging is available when required. Velnacor operates its own production base and has a long-standing supply-chain business.
Those points describe documentation and fulfillment. They do not describe a laboratory or biological outcome. For an order-specific review, send the material name, specification, box quantity, and destination through the inquiry list.
Research-use notice. All Velnacor products are intended strictly for laboratory research use only. They are not drugs, supplements, or food, and are not intended to diagnose, treat, cure, or prevent any disease. Not for human or veterinary use. Purchasers must be qualified researchers. This article is educational content for laboratory and business readers. It does not provide dosing, reconstitution, administration, diagnostic, or treatment guidance.